+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 4
Age: 15Years - 60Years
All Genders
ID06991972

Comparing Needling and Microneedling with Narrowband UVB Therapy for Localized Stable Non-Segmental Vitiligo Treatment

Led by Khyber Teaching Hospital · Updated on 2025-09-02

80

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the effectiveness of needling versus microneedling, both followed by narrowband UVB NBUVB therapy, in treating patients with localized stable non-segmental vitiligo. This randomized controlled trial focuses on comparing how well these two procedures help achieve repigmentation in the affected skin. The study includes patients aged 15 to 60 years who have had vitiligo for more than one year. Participants will be randomly assigned to one of two groups. One group will receive needling using a sterile 30G 4mm needle to implant melanocytes from nearby pigmented skin into depigmented areas, while the other group will undergo microneedling with a Dermapen device that creates controlled micro-injuries to encourage repigmentation. Both procedures are performed once every four weeks for six sessions, each followed by NBUVB phototherapy. During the 12-week study period, researchers will assess the percentage of skin repigmentation using digital planimetry and standardized photography. They will also monitor any side effects such as redness, post-inflammatory darkening, infection, and scarring. The study aims to provide detailed information about treatment results and safety by the end of the trial period.

CONDITIONS

Brief Title

Comparison of Needling and Microneedling Plus Phototherapy in Localized Vitiligo Patients

Research Team

H

Huma Gul Doctor, MBBS

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here